207 related articles for article (PubMed ID: 19142227)
1. The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.
Sawka AM; Goldstein DP; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Straus S; George SR; Abbey S; Rodin G; O'Brien MA; Gafni A; Thabane L; Goguen J; Naeem A; Magalhaes L
PLoS One; 2009; 4(1):e4191. PubMed ID: 19142227
[TBL] [Abstract][Full Text] [Related]
2. Looking under the hood of "the Cadillac of cancers:" radioactive iodine-related craniofacial side effects among patients with thyroid cancer.
Diamond-Rossi SA; Jonklaas J; Jensen RE; Kuo C; Stearns S; Esposito G; Davidson BJ; Luta G; Bloom G; Graves KD
J Cancer Surviv; 2020 Dec; 14(6):847-857. PubMed ID: 32506220
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.
Sawka AM; Lea J; Alshehri B; Straus S; Tsang RW; Brierley JD; Thabane L; Rotstein L; Gafni A; Ezzat S; Goldstein DP
Clin Endocrinol (Oxf); 2008 Apr; 68(4):610-7. PubMed ID: 17973944
[TBL] [Abstract][Full Text] [Related]
4. Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma.
Gal TJ; Streeter M; Burris J; Kudrimoti M; Ain KB; Valentino J
Thyroid; 2013 Jan; 23(1):64-9. PubMed ID: 22971127
[TBL] [Abstract][Full Text] [Related]
5. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
[TBL] [Abstract][Full Text] [Related]
6. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
[TBL] [Abstract][Full Text] [Related]
7. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.
Haymart MR; Banerjee M; Yang D; Stewart AK; Koenig RJ; Griggs JJ
Cancer; 2013 Jan; 119(2):259-65. PubMed ID: 22744940
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
Sawka AM; Straus S; Rodin G; Heus L; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Segal P; Gafni A; Thorpe KE; Goldstein DP
Cancer; 2015 Oct; 121(20):3717-26. PubMed ID: 26195199
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
10. A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment.
Sawka AM; Straus S; Gafni A; Meiyappan S; O'Brien MA; Brierley JD; Tsang RW; Rotstein L; Thabane L; Rodin G; George SR; Goldstein DP
Patient Educ Couns; 2011 Aug; 84(2):e24-7. PubMed ID: 20732775
[TBL] [Abstract][Full Text] [Related]
11. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
12. Current patterns of care in low-risk thyroid cancer-A national cross-sectional survey of Australian thyroid clinicians.
Widjaja W; Rowe CW; Oldmeadow C; Cope D; Fradgley EA; Paul C; O'Neill CJ
Endocrinol Diabetes Metab; 2023 Mar; 6(2):e398. PubMed ID: 36738092
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.
Sawka AM; Straus S; Rotstein L; Brierley JD; Tsang RW; Asa S; Segal P; Kelly C; Zahedi A; Freeman J; Solomon P; Anderson J; Thorpe KE; Gafni A; Rodin G; Goldstein DP
J Clin Oncol; 2012 Aug; 30(23):2906-11. PubMed ID: 22753906
[TBL] [Abstract][Full Text] [Related]
14. Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension.
Sawka AM; Straus S; Rodin G; Thorpe KE; Ezzat S; Gafni A; Goldstein DP
Trials; 2015 Jul; 16():302. PubMed ID: 26169592
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence radioactive iodine use for thyroid cancer.
Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.
Ahn J; Jeon MJ; Song E; Kim TY; Kim WB; Shong YK; Kim WG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):115-121. PubMed ID: 32207271
[TBL] [Abstract][Full Text] [Related]
17. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
18. Tailoring the approach to radioactive iodine treatment in thyroid cancer.
Mayson SE; Chan CM; Haugen BR
Endocr Relat Cancer; 2021 Sep; 28(10):T125-T140. PubMed ID: 34254949
[TBL] [Abstract][Full Text] [Related]
19. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
20. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
Wallner LP; Reyes-Gastelum D; Hamilton AS; Ward KC; Hawley ST; Haymart MR
J Clin Oncol; 2019 Aug; 37(24):2152-2161. PubMed ID: 31283406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
